Company Announcements

NLMK shareholders approve FY 2020 dividends

Source: RNS
RNS Number : 0446X
Novolipetsk Steel
29 April 2021

Press release

29 April 2021

NLMK shareholders approve FY2020 dividends  

At the Annual General Shareholders' Meeting (AGM) held on 29 April 2021, NLMK shareholders approved the payment of FY2020 dividends of 21.64 rubles per share. Considering the previously paid interim dividends, the amount outstanding to be paid for Q4 2020 is 7.25 rubles per share.

The date upon which the shareholders entitled to Q4 2020 dividends will be determined was set as 11 May 2021.


About NLMK Group

NLMK Group is the largest steelmaker in Russia and one of the most efficient in the world.

NLMK Group's steel products are used in various industries, from construction and machine building to the manufacturing of power-generation equipment and offshore wind turbines.

NLMK operates production facilities in Russia, Europe and the United States. The Company's steel production capacity exceeds 18 million tonnes per year.

NLMK's ordinary shares with a 20.7% free-float are traded on the Moscow Stock Exchange (ticker "NLMK") and its global depositary shares are traded on the London Stock Exchange (ticker "NLMK:LI"). The share capital of the Company is divided into 5,993,227,240 shares with a par value of RUB1.

For more details on NLMK shareholder capital, please follow the link.


IR contact info:

Dmitry Kolomytsyn, CFA

+7 (495) 504 0504

Media contact info:

Maria Simonova

+7 (915) 322 62 25

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.